Evidence map›Paper›PMID 40346724›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Multisystem failure, tipping points, and risk of Alzheimer's disease.

Simona Merlini, Edward J Bedrick, Roberta Diaz Brinton, Francesca Vitali

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Multisystem failure, tipping points, and risk of Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  7. Sex- andAlzheimer's & dementia (New York, N. Y.)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Simona MerliniCenter for Innovation in Brain Science, University of Arizona Health Sciences, Tucson, Arizona, USA.
Edward J BedrickCenter for Biomedical Informatics and Biostatistics, University of Arizona, Tucson, Arizona, USA.
Roberta Diaz BrintonCenter for Innovation in Brain Science, University of Arizona Health Sciences, Tucson, Arizona, USA.
Francesca VitaliCenter for Innovation in Brain Science, University of Arizona Health Sciences, Tucson, Arizona, USA.ORCID 0000-0003-2916-6402

Funding

Timing of Menopausal Hormone Therapy across Perimenopause to Menopause Transition: Neuroimmune System in BrainP01AG026572 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fei Yin · 2006 to 2026
$53.7M
Sex Differences in the Molecular Determinants of Alzheimer's Disease Risk: Prodromal EndophenotypeR01AG057931 · NIA · UNIVERSITY OF ARIZONA · PI BRINTON, ROBERTA EILEEN, CHANG, RUI · 2018 to 2022
$6.0M
NIA NIH HHS 5R01AG057931-02 [Sex Differences in Molecular Dementias of Alzheimer's Disease Risk: Prodromal Endophenotype]NIA NIH HHS P01 AG026572NIA NIH HHS P01AG026572 [Perimenopause in Brain Aging and Alzheimer's Disease]NIA NIH HHS R01 AG057931Women's Alzheimer's Movement to Roberta Diaz Brinton
6 · The paper itself

Abstract

introductionMedical conditions including obesity, diabetes, hyperlipidemia, and depression significantly increased risk of Alzheimer's disease (AD). However, effect of their duration, influenced by non-modifiable factors like chromosomal sex and apolipoprotein E (APOE) genotype, remains unclear.

methodsData from 5644 UKBiobank participants were analyzed using Cox regression model to identify critical tipping points based on age of onset, risk factor (RF) duration and their interaction with sex and APOE genotype.

resultsHypertension or diabetes before age 62 exerted greater AD risk than APOEε4 alone. Obesity before age 62 increased AD risk by 54%, with the risk nearly tripling between ages 62-72. Hyperlipidemia and depression were associated with age-independent risk increases of 33% and 69%, respectively. After age 72, APOEε4 became the dominant RF. DISCUSSION: Duration of AD-risk-factors can have a greater impact than APOEε4. Identification of critical age-related tipping points highlights temporal dynamics of AD progression and role of multisystem failure in AD progression. HIGHLIGHTS: AD risk factors impact AD onset, especially diagnosed between ages 62 and 72. Later diagnoses of hypertension, diabetes, and obesity delayed AD onset. Hyperlipidemia and depression increased AD risk by 33% and 69%, age-independent. APOEε4 carriers regardless of sex exhibited a higher risk increasing with age. Trajectories differed between APOEε4 carriers and non-carriers across sex.

Indexed as

Alzheimer DiseaseAgedAged, 80 and overAge of OnsetApolipoprotein E4Apolipoproteins EDepressionDiabetes MellitusFemaleGenotypeHumansHyperlipidemiasHypertensionMaleMiddle AgedObesityApolipoprotein E4Apolipoproteins EAD prevention strategiesAD‐risk‐factorsAlzheimer's disease (AD)APOE genotypechromosomal sexCox proportional hazard model (CPHM)depressionhyperlipidemia (HLP)hypertension (HTN)late onset Alzheimer's disease (LOAD)modifiable risk factorsobesitytype 2 diabetes (T2D)UK Biobankunmodifiable risk factors

Identifiers

PMID40346724
PMCPMC12064414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.